Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
ChromaDex Corp has a consensus price target of $5.35 based on the ratings of 5 analysts. The high is $7 issued by Roth Capital on March 8, 2022. The low is $2.4 issued by B. Riley Securities on August 11, 2022. The 3 most-recent analyst ratings were released by HC Wainwright & Co., HC Wainwright & Co., and Roth MKM on August 9, 2024, July 15, 2024, and June 12, 2024, respectively. With an average price target of $6 between HC Wainwright & Co., HC Wainwright & Co., and Roth MKM, there's an implied 65.29% upside for ChromaDex Corp from these most-recent analyst ratings.
1calculated from analyst ratings
The latest price target for ChromaDex (NASDAQ:CDXC) was reported by HC Wainwright & Co. on August 9, 2024. The analyst firm set a price target for $6.00 expecting CDXC to rise to within 12 months (a possible 65.29% upside). 6 analyst firms have reported ratings in the last year.
The latest analyst rating for ChromaDex (NASDAQ:CDXC) was provided by HC Wainwright & Co., and ChromaDex reiterated their buy rating.
There is no last upgrade for ChromaDex
The last downgrade for ChromaDex Corp happened on August 16, 2022 when Oppenheimer changed their price target from N/A to N/A for ChromaDex Corp.
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of ChromaDex, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for ChromaDex was filed on August 9, 2024 so you should expect the next rating to be made available sometime around August 9, 2025.
While ratings are subjective and will change, the latest ChromaDex (CDXC) rating was a reiterated with a price target of $6.00 to $6.00. The current price ChromaDex (CDXC) is trading at is $3.63, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.